CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Palinopsia.

BACKGROUND: Palinopsia is a visual phenomenon that has been associated with brain neoplasia, epilepsy, trauma, systemic disease, psychiatric illness, and illicit as well as prescribed drug use. Despite some resemblance to diplopia, polyopia, and physiologic afterimage formation, palinopsia is actually a distinct entity often suggestive of disease through its distinct signs and symptoms. Careful patient history, visual field testing, and neuroimaging are among the tools used to diagnose palinopsia.

CASE REPORTS: Four case reports of patients with palinopsia are presented. With the first patient, the palinopsia was associated with extensive lysergic acid diethylamide (LSD) use. The second patient's palinopsia was determined to be secondary to head trauma from a motor vehicle accident. The third patient began to experience palinopsia after he had been prescribed trazodone for insomnia. The fourth patient was found to have multiple potential etiologies. These 4 unique patients highlight the causes and management of palinopsia.

CONCLUSIONS: Optometrists should be aware of the symptoms of palinopsia to enable them to recognize this phenomenon and minimize the chance of misdiagnosis. Learning the physiologic mechanisms behind this uncommon disorder can help the clinician correctly identify its cause. Although palinopsia itself is not a disease, it is indicative of a disease, and the symptoms of palinopsia may be a manifestation of a serious underlying systemic dysfunction that could warrant treatment. In addition, identifying the symptoms of palinopsia can put patients at ease with regard to the often disturbing visual symptoms.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app